Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RG1068-enhanced MRCP in pancreatitis
NCT00660335Phase 3Completed
- Sponsor
- Repligen Corporation
- Start
- Mar 2008
- Primary completion
- Oct 2009
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of lobeglitazone in pancreatitis, sponsored by Repligen Corporation. Started Mar 2008; status: completed.
02
Drugs
lobeglitazone
03
Conditions
pancreatitis
Beyond the preview
Go deeper on NCT00660335.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00660335.